The Middle East and Africa q-PCR reagents market was valued at USD 24.94 million in 2025 and is projected to reach USD 34.92 million by 2033, growing at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady expansion driven by increasing adoption of molecular diagnostics, rising prevalence of infectious and chronic diseases, and growing investment in advanced laboratory infrastructure across key countries in the region. Strengthening healthcare systems and expanding access to real-time diagnostic technologies are further supporting market growth.
4 vistas